With around 150 employees, the Aenova site in Marburg manufactures delayed-release tablets and capsules as well as moisture-sensitive dosage forms.

Scheffczik studied chemistry with a focus on biochemistry and earned his doctorate at the Institute of Virology at Philipps University in Marburg. After holding various development and management positions at international research-based pharmaceutical companies, he joined Aenova in 2021, initially as Head of Manufacturing Science & Technology.

"With Dr. Scheffczik we have a long-standing experienced manager and expert who knows the industry and Aenova very well," commented Jan Kengelbach, CEO of Aenova.